Metoprolol treatment lowers thrombospondin-4 expression in rats with myocardial infarction and left ventricular hypertrophy

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 3, 2010, Pages 709-717

  Mustonen, Erja ^a   Leskinen, Hanna ^a   Aro, Jani ^a   Luodonpää, Marja ^a   Vuolteenaho, Olli ^a   Ruskoaho, Heikki ^a   Rysä, Jaana ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; MESSENGER RNA; METOPROLOL; PLASMA PROTEIN; THROMBOSPONDIN 1; THROMBOSPONDIN 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART DISEASE; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; METOPROLOL; MYOCARDIAL INFARCTION; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THROMBOSPONDINS;

RATTUS;

EID: 77955803946     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00564.x     Document Type: Article

References (46)

1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000 35 : 569 82.
2. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999 79 : 215 62.
3. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 2003 108 : 1395 403.
4. Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res 2005 66 : 22 32.
5. Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 2006 48 : 326 41.
6. Mustonen E, Aro J, Puhakka J, Ilves M, Soini Y, Leskinen H et al. Thrombospondin-4 expression is rapidly upregulated by cardiac overload. Biochem Biophys Res Commun 2008 373 : 186 91.
7. Schellings MW, Pinto YM, Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res 2004 64 : 24 31.
8. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005 111 : 2935 42.
9. Zhang XM, Shen F, Xv ZY, Yan ZY, Han S. Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats. Int J Cardiol 2005 105 : 192 7.
10. Chatila K, Ren G, Xia Y, Huebener P, Bujak M, Frangogiannis NG. The role of the thrombospondins in healing myocardial infarcts. Cardiovasc Hematol Agents Med Chem 2007 5 : 21 7.
11. Moens AL, Cingolani O, Spinale FS, Kass DA. Exacerbated cardiac remodeling to pressure-overload in mice lacking thrombospondin-4. Hypertension 2008 52 : 749. (Abstract)
12. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. Beta-Adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000 101 : 2103 9.
13. Sun YL, Hu SJ, Wang LH, Hu Y, Zhou JY. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats. Chest 2005 128 : 1812 21.
14. Maczewski M, Mackiewicz U. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2 + handling in the post-infarction rat heart. Cardiovasc Res 2008 79 : 42 51.
15. Udelson JE. Ventricular remodeling in heart failure and the effect of beta-blockade. Am J Cardiol 2004 93 : 43B 8B.
16. Luodonpää M, Leskinen H, Ilves M, Vuolteenaho O, Ruskoaho H. Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats. Am J Physiol Regul Integr Comp Physiol 2004 286 : R1085 92.
17. Tenhunen O, Soini Y, Ilves M, Rysä J, Tuukkanen J, Serpi R et al. p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms. FASEB J 2006 20 : 1907 1909.
18. Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression. Circ Res 1997 81 : 694 702.
19. Rysä J, Aro J, Ruskoaho H. Early left ventricular gene expression profile in response to increase in blood pressure. Blood Press 2006 15 : 375 83.
20. Tenhunen O, Rysä J, Ilves M, Soini Y, Ruskoaho H, Leskinen H. Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart. Circ Res 2006 99 : 485 93.
21. Majalahti-Palviainen T, Hirvinen M, Tervonen V, Ilves M, Ruskoaho H, Vuolteenaho O. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology 2000 141 : 731 40.
22. Vuolteenaho O, Koistinen P, Martikkala V, Takala T, Leppäluoto J. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion. Am J Physiol 1992 263 : R647 52.
23. Rysä J, Leskinen H, Ilves M, Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 2005 45 : 927 33.
24. Wei S, Chow LT, Sanderson JE. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol 2000 36 : 276 81.
25. Omerovic E, Bollano E, Mobini R, Madhu B, Kujacic V, Soussi B et al. Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling. Biochem Biophys Res Commun 2001 281 : 491 8.
26. Omerovic E, Bollano E, Soussi B, Waagstein F. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure. Eur J Heart Fail 2003 5 : 725 32.
27. Yang Y, Tang Y, Ruan Y, Wang Y, Gao R, Chen J et al. Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats. Jpn Heart J 2003 44 : 979 88.
28. Watanabe K, Juan W, Narasimman G, Ma M, Inoue M, Saito Y et al. Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure. J Cardiovasc Pharmacol 2003 41 (Suppl 1 S99 103.
29. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 2002 346 : 1357 65.
30. Mendez RE, Pfeffer JM, Ortola FV, Bloch KD, Anderson S, Seidman JG et al. Atrial natriuretic peptide transcription, storage, and release in rats with myocardial infarction. Am J Physiol 1987 253 : H1449 55.
31. Drexler H, Hanze J, Finckh M, Lu W, Just H, Lang RE. Atrial natriuretic peptide in a rat model of cardiac failure. Atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation 1989 79 : 620 33.
32. Sawada Y, Inoue M, Kanda T, Sakamaki T, Tanaka S, Minamino N et al. Co-elevation of brain natriuretic peptide and proprotein-processing endoprotease furin after myocardial infarction in rats. FEBS Lett 1997 400 : 177 82.
33. Maczewski M, Mackiewicz U. Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart. Cardiovasc Pathol 2007 16 : 79 84.
34. Morii N, Nakao K, Kihara M, Sugawara A, Sakamoto M, Yamori Y et al. Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontaneously hypertensive rats (SHR) and SHR stroke-prone. Biochem Biophys Res Commun 1986 135 : 74 81.
35. Ruskoaho H, Leppäluoto J. Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothalamus, and plasma of genetically hypertensive rats. Circ Res 1988 62 : 384 394. (Pubitemid 18041960)
36. Magga J, Marttila M, Mäntymaa P, Vuolteenaho O, Ruskoaho H. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats. Endocrinology 1994 134 : 2505 15.
37. Yoshimoto T, Naruse M, Irie K, Tanabe A, Seki T, Tanaka M et al. Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides. Eur J Pharmacol 1998 351 : 61 6.
38. Yoshimoto T, Naruse M, Tanabe A, Naruse K, Seki T, Imaki T et al. Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism. Endocrinology 1998 139 : 81 8.
39. Asai T, Kushiro T, Fujita H, Kanmatsuse K. Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists andor the angiotensin II type 1 receptor blocker under comparable blood pressure reduction. Hypertens Res 2005 28 : 79 87.
40. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003 24 : 341 56.
41. Varagic J, Susic D, Frohlich ED. Low-dose ACE with alpha- or beta-adrenergic receptor inhibitors have beneficial SHR cardiovascular effects. J Cardiovasc Pharmacol Ther 2001 6 : 57 63.
42. Ziegelhoffer-Mihalovicova B, Arnold N, Marx G, Tannapfel A, Zimmer HG, Rassler B. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats. Life Sci 2006 79 : 838 46.
43. Ogawa Y, Nakao K, Mukoyama M, Hosoda K, Shirakami G, Arai H et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res 1991 69 : 491 500.
44. Dagnino L, Lavigne JP, Nemer M. Increased transcripts for B-type natriuretic peptide in spontaneously hypertensive rats. Quantitative polymerase chain reaction for atrial and brain natriuretic peptide transcripts. Hypertension 1992 20 : 690 700.
45. Arai H, Nakao K, Saito Y, Morii N, Sugawara A, Yamada T et al. Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ Res 1988 62 : 926 30.
46. Ohta K, Kim S, Iwao H. Role of angiotensin-converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development. Hypertension 1996 28 : 627 34.